39
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Former inmates are at high risk for death from drug overdose, especially in the immediate post-release period. The purpose of the study is to understand the drug use experiences, perceptions of overdose risk, and experiences with overdose among former prisoners.

          Methods

          This qualitative study included former prison inmates (N = 29) who were recruited within two months after their release. Interviewers conducted in-person, semi-structured interviews which explored participants' experiences and perceptions. Transcripts were analyzed utilizing a team-based method of inductive analysis.

          Results

          The following themes emerged: 1) Relapse to drugs and alcohol occurred in a context of poor social support, medical co-morbidity and inadequate economic resources; 2) former inmates experienced ubiquitous exposure to drugs in their living environments; 3) intentional overdose was considered "a way out" given situational stressors, and accidental overdose was perceived as related to decreased tolerance; and 4) protective factors included structured drug treatment programs, spirituality/religion, community-based resources (including self-help groups), and family.

          Conclusions

          Former inmates return to environments that strongly trigger relapse to drug use and put them at risk for overdose. Interventions to prevent overdose after release from prison may benefit from including structured treatment with gradual transition to the community, enhanced protective factors, and reductions of environmental triggers to use drugs.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.

          Administering naloxone hydrochloride (naloxone) during an opioid overdose reverses the overdose and can prevent death. Although typically delivered via intramuscular or intravenous injection, naloxone may be delivered via intranasal spray device. In August 2006, the Boston Public Health Commission passed a public health regulation that authorized an opioid overdose prevention program that included intranasal naloxone education and distribution of the spray to potential bystanders. Participants were taught by trained nonmedical needle exchange staff. After 15 months, the program provided training and intranasal naloxone to 385 participants who reported 74 successful overdose reversals. Problems with intranasal naloxone were uncommon. Overdose prevention education with distribution of intranasal naloxone is a feasible public health intervention to address opioid overdose.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates.

            We investigated whether there were gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates and whether substance dependence mediated any gender differences found. We analyzed data from a nationally representative survey of 6982 US jail inmates. Weighted estimates of disease prevalence were calculated by gender for chronic medical disorders (cancer, hypertension, diabetes, arthritis, asthma, hepatitis, and cirrhosis), psychiatric disorders (depressive, bipolar, psychotic, posttraumatic stress, anxiety, and personality), and substance-dependence disorders. We conducted logistic regression to examine the relationship between gender and these disorders. Compared with men, women had a significantly higher prevalence of all medical and psychiatric conditions (P < or = .01 for each) and drug dependence (P < .001), but women had a lower prevalence of alcohol dependence (P < .001). Gender differences persisted after adjustment for sociodemographic factors and substance dependence. Women in jail had a higher burden of chronic medical disorders, psychiatric disorders, and drug dependence than men, including conditions found more commonly in men in the general population. Thus, there is a need for targeted attention to the chronic medical, psychiatric, and drug-treatment needs of women at risk for incarceration, both in jail and after release.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mortality from overdose among injecting drug users recently released from prison: database linkage study.

              To assess whether injecting drug users have a higher than usual risk of death from overdose in the 2 weeks after release from prison. Soundex coding of surnames and information on date of birth were used to link entry and release dates from the local prison between 1983 and 1994 with clinical data from Edinburgh City Hospital's cohort of male injecting drug users who are infected with HIV. Edinburgh City Hospital and Edinburgh Prison. 316/332 male injecting drug users infected with HIV in the City Hospital HIV cohort; 16 were excluded because they were enrolled after developing AIDS or because their precise date of death was not available. Relative risk of dying from overdose before developing AIDS and relative risk of dying of all causes before developing AIDS during the 2 weeks after release from prison; this was compared with relative risks of death during other time at liberty. 238/316 (75%) injecting drug users served time in the prison between 1983 and 1994. 33 out of 316 injecting drug users who were infected with HIV died before developing AIDS during 517,177 days at risk. 20 of these men died of an overdose; 6 of these deaths occurred within 2 weeks of release during 5903 days at risk. Death rates from overdose before the development of AIDS were 1.02/1000 days during the 2 weeks after release (recently released) and 0.029/1000 days during other times of liberty. The relative risk of death from overdose became 7.7 (1.5 to 39.1) after temporal matching (when the comparison was limited to the first 2 weeks after release v the next 10 weeks). The crude relative risk in an analysis combining stratified prison term and the 2 weeks after release was 4.5 (1.7 to 11.7) for death from overdose. After temporal matching these risks became 1.8 (0.4 to 9.2). Prisons should evaluate interventions to reduce the risk of death from overdose after release.
                Bookmark

                Author and article information

                Journal
                Addict Sci Clin Pract
                Addict Sci Clin Pract
                Addiction Science & Clinical Practice
                BioMed Central
                1940-0632
                1940-0640
                2012
                15 March 2012
                : 7
                : 1
                : 3
                Affiliations
                [1 ]Division of General Internal Medicine and Division of Substance Dependence, University of Colorado School of Medicine, Mail Stop B180, 12631 East 17th Avenue, Aurora, CO 80045, USA
                [2 ]Denver Health Medical Center, 501 East 28th Street, Denver, CO 80045, USA
                [3 ]Division of General Internal Medicine, University of Colorado School of Medicine, Mail Stop B180, 12631 East 17th Avenue, Aurora, CO 80045, USA
                [4 ]Division of Substance Dependence, University of Colorado School of Medicine, 1741 Vine Street, Denver, CO 80206, USA
                [5 ]Institute for Health Research, Kaiser Permanente Colorado, 10065 East Harvard Avenue, #300, Denver, CO 80231, USA
                [6 ]Department of Epidemiology, Colorado School of Public Health, 13001 East 17th Place, Mail Stop B119, Aurora, CO 80045, USA
                [7 ]Denver Health Medical Center, 777 Bannock Street, Denver, CO 80204, USA
                [8 ]Division of General Internal Medicine, University of Colorado School of Medicine, Mail Stop B180, 12631 East 17th Avenue, Aurora CO 80045, USA
                [9 ]Division of Substance Dependence, University of Colorado School of Medicine, 1741 Vine Street, Denver, CO 80206, USA
                [10 ]Institute for Health Research, Kaiser Permanente Colorado, 10065 East Harvard Avenue, #300, Denver, CO 80231, USA
                Article
                1940-0640-7-3
                10.1186/1940-0640-7-3
                3414824
                22966409
                9dccc76b-d571-4abe-a8b0-8796dc5d131c
                Copyright ©2012 Binswanger et al; licensee BioMed Central Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 18 October 2011
                : 15 March 2012
                Categories
                Research

                Health & Social care
                drug use,relapse,prisoners,overdose,prison re-entry
                Health & Social care
                drug use, relapse, prisoners, overdose, prison re-entry

                Comments

                Comment on this article